Bio-similar drug development and accessible drugs in the market for the treatment of Alzheimer's Disease: Current status
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.
Yazar: | Tamanna, Mst. Taskia |
---|---|
Diğer Yazarlar: | Sharmin, Dr. Sabrina |
Materyal Türü: | Tez |
Dil: | English |
Baskı/Yayın Bilgisi: |
Brac University
2023
|
Konular: | |
Online Erişim: | http://hdl.handle.net/10361/18146 |
Benzer Materyaller
-
Progress of finding latent therapeutic activity of vaccine for Alzheimer’s disease
Yazar:: Hassan, Md. Muhtaz
Baskı/Yayın Bilgisi: (2020) -
Role of protein’s and future treatment options for Alzheimer’s Disease
Yazar:: Islam, Md. Irfath
Baskı/Yayın Bilgisi: (2023) -
Efficacy of Rivastigmine in Alzheimer’s disease- A structured seview
Yazar:: Alim, Abdul
Baskı/Yayın Bilgisi: (2023) -
Marine compounds in the treatment of Alzheimer’s disease
Yazar:: Parveen, Sanjana
Baskı/Yayın Bilgisi: (2022) -
Gender-specific Rhabdomyolysis risk in Alzheimer’s disease patients receiving memantine: a pharmacovigilance study
Yazar:: Tabassum, Nadira
Baskı/Yayın Bilgisi: (2024)